212 related articles for article (PubMed ID: 33011861)
21. Treatment of elderly advanced gastric cancer patients with 5-fluorouracil and leucovorin combination.
Cascinu S; Fedeli A; Luzi Fedeli S; Catalano G
J Chemother; 1992 Jun; 4(3):185-8. PubMed ID: 1517814
[TBL] [Abstract][Full Text] [Related]
22. Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience.
Petrioli R; Francini E; Roviello F; Marrelli D; Fiaschi AI; Laera L; Rossi G; Bianco V; Brozzetti S; Roviello G
Cancer Chemother Pharmacol; 2015 May; 75(5):941-7. PubMed ID: 25743995
[TBL] [Abstract][Full Text] [Related]
23. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
24. [A Case of Hyperammonemia Induced by Chemotherapy with 5-Fluorouracil for Metastatic Colon Cancer].
Tokuyama S; Fukunaga M; Konishi K; Honda S; Yukimoto R; Okamoto A; Saito A; Okada K; Ota H; Yokoyama S; Miki H; Kobayashi K
Gan To Kagaku Ryoho; 2018 Apr; 45(4):743-745. PubMed ID: 29650854
[TBL] [Abstract][Full Text] [Related]
25. Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Sobrero A; Zaniboni A; Frassineti GL; Aschele C; Guglielmi A; Giuliani R; Ravaioli A; Lanfranco C; Caroti C; Arnoldi E; Barni S; Gallo L; Pessi MA; Turci D; Cortesi E; Grossi F; Frontini L; Piazza E; Bruzzi P; Labianca R
Ann Oncol; 2000 Nov; 11(11):1413-20. PubMed ID: 11142481
[TBL] [Abstract][Full Text] [Related]
26. Systemic absorption of 5-fluorouracil during vitrectomy.
Creten O; Spileers W; Stalmans P
Am J Ophthalmol; 2006 Jul; 142(1):194-6. PubMed ID: 16815286
[TBL] [Abstract][Full Text] [Related]
27. Limited sampling model for the analysis of 5-fluorouracil pharmacokinetics in adjuvant chemotherapy for colorectal cancer.
Di Paolo A; Danesi R; Vannozzi F; Falcone A; Mini E; Cionini L; Ibrahim T; Amadori D; Del Tacca M
Clin Pharmacol Ther; 2002 Dec; 72(6):627-37. PubMed ID: 12496744
[TBL] [Abstract][Full Text] [Related]
28. Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer.
Hospers GA; Schaapveld M; Nortier JW; Wils J; van Bochove A; de Jong RS; Creemers GJ; Erjavec Z; de Gooyer DJ; Slee PH; Gerrits CJ; Smit JM; Mulder NH
Ann Oncol; 2006 Mar; 17(3):443-9. PubMed ID: 16500914
[TBL] [Abstract][Full Text] [Related]
29. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
[TBL] [Abstract][Full Text] [Related]
30. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
31. 5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer.
Jodrell DI; Stewart M; Aird R; Knowles G; Bowman A; Wall L; McLean C
Br J Cancer; 2001 Mar; 84(5):600-3. PubMed ID: 11237378
[TBL] [Abstract][Full Text] [Related]
32. Fluorouracil-induced Hyperammonemia in a Patient with Colorectal Cancer.
Thomas SA; Tomeh N; Theard S
Anticancer Res; 2015 Dec; 35(12):6761-3. PubMed ID: 26637893
[TBL] [Abstract][Full Text] [Related]
33. Salvage chemotherapy with biweekly irinotecan, plus 5-fluorouracil and leucovorin in patients with advanced gastric cancer previously treated with fluoropyrimidine, platinum, and taxane.
Sym SJ; Ryu MH; Lee JL; Chang HM; Kim TW; Lee SS; Lee JS; Kang YK
Am J Clin Oncol; 2008 Apr; 31(2):151-6. PubMed ID: 18391599
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of bolus 5-fluorouracil: relationship between dose, plasma concentrations, area-under-the-curve and toxicity.
Codacci-Pisanelli G; Pinedo HM; Lankelma J; Van Groeningen CJ; Van Kuilenburg AB; Van Gennip AH; Peters GJ
J Chemother; 2005 Jun; 17(3):315-20. PubMed ID: 16038526
[TBL] [Abstract][Full Text] [Related]
35. A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma.
Gennatas C; Papaxoinis G; Michalaki V; Mouratidou D; Andreadis C; Tsavaris N; Pafiti A
J Chemother; 2006 Oct; 18(5):538-44. PubMed ID: 17127232
[TBL] [Abstract][Full Text] [Related]
36. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
[TBL] [Abstract][Full Text] [Related]
37. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
[TBL] [Abstract][Full Text] [Related]
38. [Plasma concentrations of 5-fluorouracil and F-beta-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracil].
Yamada Y
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():37-41. PubMed ID: 16897970
[TBL] [Abstract][Full Text] [Related]
39. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).
Di Costanzo F; Bartolucci R; Calabresi F; Sofra M; Marzola M; Belsanti V; Boni C; Bacchi M
Ann Oncol; 1992 May; 3(5):371-6. PubMed ID: 1616890
[TBL] [Abstract][Full Text] [Related]
40. [A Case Altered Consciousness Due to 5-Fluorouracil-Induced Hyperammonemia in a Patient with Recurrent Colorectal Cancer].
Sawazaki S; Numata M; Ju M; Morita J; Komori K; Maezawa Y; Amano S; Aoyama T; Tamagawa H; Sato T; Oshima T; Mushiake H; Yukawa N; Masuda M; Rino Y
Gan To Kagaku Ryoho; 2019 Oct; 46(10):1632-1634. PubMed ID: 31631158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
